Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon.

Molecular therapy. Nucleic acids

Broos K, Van der Jeught K, Puttemans J, Goyvaerts C, Heirman C, Dewitte H, Verbeke R, Lentacker I, Thielemans K, Breckpot K.
PMID: 27327138
Mol Ther Nucleic Acids. 2016 Jun 21;5(6):e326. doi: 10.1038/mtna.2016.38.

Cancer vaccines based on mRNA are extensively studied. The fragile nature of mRNA has instigated research into carriers that can protect it from ribonucleases and as such enable its systemic use. However, carrier-mediated delivery of mRNA has been linked...

Cite
Broos K, Van der Jeught K, Puttemans J, et al. Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon. Mol Ther Nucleic Acids. 2016;5(6):e326doi: 10.1038/mtna.2016.38.
Broos, K., Van der Jeught, K., Puttemans, J., Goyvaerts, C., Heirman, C., Dewitte, H., Verbeke, R., Lentacker, I., Thielemans, K., & Breckpot, K. (2016). Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon. Molecular therapy. Nucleic acids, 5(6), e326. https://doi.org/10.1038/mtna.2016.38
Broos, Katrijn, et al. "Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon." Molecular therapy. Nucleic acids vol. 5,6 (2016): e326. doi: https://doi.org/10.1038/mtna.2016.38
Broos K, Van der Jeught K, Puttemans J, Goyvaerts C, Heirman C, Dewitte H, Verbeke R, Lentacker I, Thielemans K, Breckpot K. Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I Interferon. Mol Ther Nucleic Acids. 2016 Jun 21;5(6):e326. doi: 10.1038/mtna.2016.38. PMID: 27327138; PMCID: PMC5022130.
Copy Download .nbib Format: NLM
Strontium fails to induce Ca.

Human reproduction open

Lu Y, Reddy R, Ferrer Buitrago M, Vander Jeught M, Neupane J, De Vos WH, Van den Abbeel E, Lierman S, De Sutter P, Heindryckx B.
PMID: 30895246
Hum Reprod Open. 2018 Apr 09;2018(3):hoy005. doi: 10.1093/hropen/hoy005. eCollection 2018.

STUDY QUESTION: Are the transient receptor potential cation channels vanilloid 3 (TRPV3) present and able to mediate strontium (SrSUMMARY ANSWER: SrWHAT IS KNOWN ALREADY: Selective activation of TRPV3 by agonists induces CaSTUDY DESIGN SIZE DURATION: The protein distribution (PARTICIPANTS/MATERIALS...

Cite
Lu Y, Reddy R, Ferrer Buitrago M, et al. Strontium fails to induce Ca. Hum Reprod Open. 2018;2018(3):hoy005doi: 10.1093/hropen/hoy005.
Lu, Y., Reddy, R., Ferrer Buitrago, M., Vander Jeught, M., Neupane, J., De Vos, W. H., Van den Abbeel, E., Lierman, S., De Sutter, P., & Heindryckx, B. (2018). Strontium fails to induce Ca. Human reproduction open, 2018(3), hoy005. https://doi.org/10.1093/hropen/hoy005
Lu, Y, et al. "Strontium fails to induce Ca." Human reproduction open vol. 2018,3 (2018): hoy005. doi: https://doi.org/10.1093/hropen/hoy005
Lu Y, Reddy R, Ferrer Buitrago M, Vander Jeught M, Neupane J, De Vos WH, Van den Abbeel E, Lierman S, De Sutter P, Heindryckx B. Strontium fails to induce Ca. Hum Reprod Open. 2018 Apr 09;2018(3):hoy005. doi: 10.1093/hropen/hoy005. eCollection 2018. PMID: 30895246; PMCID: PMC6276696.
Copy Download .nbib Format: NLM
Time to Move On: The Impending Need for a New Disease-specific Comorbidity Index for Bladder Cancer Patients Undergoing Robot-assisted Radical Cystectomy.

European urology focus

Lambert E, D'Hondt F, Mazzone E, Vollemaere J, Larcher A, Van Der Jeugt J, Devos G, Uvin P, Goossens M, Poelaert F, De Naeyer G, Schatteman P, Collins J, Mottrie A, Dell'Oglio P.
PMID: 31201083
Eur Urol Focus. 2021 Jan;7(1):139-141. doi: 10.1016/j.euf.2019.05.015. Epub 2019 Jun 11.

The Charlson comorbidity index is an outdated comorbidity assessment tool which is not disease specific and is not applicable to contemporary BCa patients.

Cite
Lambert E, D'Hondt F, Mazzone E, et al. Time to Move On: The Impending Need for a New Disease-specific Comorbidity Index for Bladder Cancer Patients Undergoing Robot-assisted Radical Cystectomy. Eur Urol Focus. 2019;7(1):139-141doi: 10.1016/j.euf.2019.05.015.
Lambert, E., D'Hondt, F., Mazzone, E., Vollemaere, J., Larcher, A., Van Der Jeugt, J., Devos, G., Uvin, P., Goossens, M., Poelaert, F., De Naeyer, G., Schatteman, P., Collins, J., Mottrie, A., & Dell'Oglio, P. (2021). Time to Move On: The Impending Need for a New Disease-specific Comorbidity Index for Bladder Cancer Patients Undergoing Robot-assisted Radical Cystectomy. European urology focus, 7(1), 139-141. https://doi.org/10.1016/j.euf.2019.05.015
Lambert, Edward, et al. "Time to Move On: The Impending Need for a New Disease-specific Comorbidity Index for Bladder Cancer Patients Undergoing Robot-assisted Radical Cystectomy." European urology focus vol. 7,1 (2021): 139-141. doi: https://doi.org/10.1016/j.euf.2019.05.015
Lambert E, D'Hondt F, Mazzone E, Vollemaere J, Larcher A, Van Der Jeugt J, Devos G, Uvin P, Goossens M, Poelaert F, De Naeyer G, Schatteman P, Collins J, Mottrie A, Dell'Oglio P. Time to Move On: The Impending Need for a New Disease-specific Comorbidity Index for Bladder Cancer Patients Undergoing Robot-assisted Radical Cystectomy. Eur Urol Focus. 2021 Jan;7(1):139-141. doi: 10.1016/j.euf.2019.05.015. Epub 2019 Jun 11. PMID: 31201083.
Copy Download .nbib Format: NLM
Introducing SPeDE: High-Throughput Dereplication and Accurate Determination of Microbial Diversity from Matrix-Assisted Laser Desorption-Ionization Time of Flight Mass Spectrometry Data.

mSystems

Dumolin C, Aerts M, Verheyde B, Schellaert S, Vandamme T, Van der Jeugt F, De Canck E, Cnockaert M, Wieme AD, Cleenwerck I, Peiren J, Dawyndt P, Vandamme P, Carlier A.
PMID: 31506264
mSystems. 2019 Sep 10;4(5). doi: 10.1128/mSystems.00437-19.

The isolation of microorganisms from microbial community samples often yields a large number of conspecific isolates. Increasing the diversity covered by an isolate collection entails the implementation of methods and protocols to minimize the number of redundant isolates. Matrix-assisted...

Cite
Dumolin C, Aerts M, Verheyde B, et al. Introducing SPeDE: High-Throughput Dereplication and Accurate Determination of Microbial Diversity from Matrix-Assisted Laser Desorption-Ionization Time of Flight Mass Spectrometry Data. mSystems. 2019;4(5)doi: 10.1128/mSystems.00437-19.
Dumolin, C., Aerts, M., Verheyde, B., Schellaert, S., Vandamme, T., Van der Jeugt, F., De Canck, E., Cnockaert, M., Wieme, A. D., Cleenwerck, I., Peiren, J., Dawyndt, P., Vandamme, P., & Carlier, A. (2019). Introducing SPeDE: High-Throughput Dereplication and Accurate Determination of Microbial Diversity from Matrix-Assisted Laser Desorption-Ionization Time of Flight Mass Spectrometry Data. mSystems, 4(5), . https://doi.org/10.1128/mSystems.00437-19
Dumolin, Charles, et al. "Introducing SPeDE: High-Throughput Dereplication and Accurate Determination of Microbial Diversity from Matrix-Assisted Laser Desorption-Ionization Time of Flight Mass Spectrometry Data." mSystems vol. 4,5 (2019). doi: https://doi.org/10.1128/mSystems.00437-19
Dumolin C, Aerts M, Verheyde B, Schellaert S, Vandamme T, Van der Jeugt F, De Canck E, Cnockaert M, Wieme AD, Cleenwerck I, Peiren J, Dawyndt P, Vandamme P, Carlier A. Introducing SPeDE: High-Throughput Dereplication and Accurate Determination of Microbial Diversity from Matrix-Assisted Laser Desorption-Ionization Time of Flight Mass Spectrometry Data. mSystems. 2019 Sep 10;4(5). doi: 10.1128/mSystems.00437-19. PMID: 31506264; PMCID: PMC6739102.
Copy Download .nbib Format: NLM
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity.

Nature biomedical engineering

Zhou Z, Van der Jeught K, Fang Y, Yu T, Li Y, Ao Z, Liu S, Zhang L, Yang Y, Eyvani H, Cox ML, Wang X, He X, Ji G, Schneider BP, Guo F, Wan J, Zhang X, Lu X.
PMID: 34725507
Nat Biomed Eng. 2021 Nov;5(11):1320-1335. doi: 10.1038/s41551-021-00805-x. Epub 2021 Nov 01.

In breast cancer, genetic heterogeneity, the lack of actionable targets and immune evasion all contribute to the limited clinical response rates to immune checkpoint blockade therapy. Here, we report a high-throughput screen based on the functional interaction of mouse-...

Cite
Zhou Z, Van der Jeught K, Fang Y, et al. An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity. Nat Biomed Eng. 2021;5(11):1320-1335doi: 10.1038/s41551-021-00805-x.
Zhou, Z., Van der Jeught, K., Fang, Y., Yu, T., Li, Y., Ao, Z., Liu, S., Zhang, L., Yang, Y., Eyvani, H., Cox, M. L., Wang, X., He, X., Ji, G., Schneider, B. P., Guo, F., Wan, J., Zhang, X., & Lu, X. (2021). An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity. Nature biomedical engineering, 5(11), 1320-1335. https://doi.org/10.1038/s41551-021-00805-x
Zhou, Zhuolong, et al. "An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity." Nature biomedical engineering vol. 5,11 (2021): 1320-1335. doi: https://doi.org/10.1038/s41551-021-00805-x
Zhou Z, Van der Jeught K, Fang Y, Yu T, Li Y, Ao Z, Liu S, Zhang L, Yang Y, Eyvani H, Cox ML, Wang X, He X, Ji G, Schneider BP, Guo F, Wan J, Zhang X, Lu X. An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity. Nat Biomed Eng. 2021 Nov;5(11):1320-1335. doi: 10.1038/s41551-021-00805-x. Epub 2021 Nov 01. PMID: 34725507; PMCID: PMC8647932.
Copy Download .nbib Format: NLM
Deep neural networks for single shot structured light profilometry.

Optics express

Van der Jeught S, Dirckx JJJ.
PMID: 31252926
Opt Express. 2019 Jun 10;27(12):17091-17101. doi: 10.1364/OE.27.017091.

In 3D optical metrology, single-shot structured light profilometry techniques have inherent advantages over their multi-shot counterparts in terms of measurement speed, optical setup simplicity, and robustness to motion artifacts. In this paper, we present a new approach to extract...

Cite
Van der Jeught S, Dirckx JJJ. Deep neural networks for single shot structured light profilometry. Opt Express. 2019;27(12):17091-17101doi: 10.1364/OE.27.017091.
Van der Jeught, S., & Dirckx, J. J. J. (2019). Deep neural networks for single shot structured light profilometry. Optics express, 27(12), 17091-17101. https://doi.org/10.1364/OE.27.017091
Van der Jeught, Sam, and Dirckx, Joris J J. "Deep neural networks for single shot structured light profilometry." Optics express vol. 27,12 (2019): 17091-17101. doi: https://doi.org/10.1364/OE.27.017091
Van der Jeught S, Dirckx JJJ. Deep neural networks for single shot structured light profilometry. Opt Express. 2019 Jun 10;27(12):17091-17101. doi: 10.1364/OE.27.017091. PMID: 31252926.
Copy Download .nbib Format: NLM
Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer.

Nature nanotechnology

Xu J, Liu Y, Li Y, Wang H, Stewart S, Van der Jeught K, Agarwal P, Zhang Y, Liu S, Zhao G, Wan J, Lu X, He X.
PMID: 30837690
Nat Nanotechnol. 2019 May;14(5):496. doi: 10.1038/s41565-019-0417-y.

The Supplementary Information originally published with this Article was an older version, in which 'IFN-γ' was misspelled 'INF-γ' in Supplementary Fig. 9 and the β-Actin blot in Supplementary Fig. 13 was the wrong image. The Supplementary Information has now...

Cite
Xu J, Liu Y, Li Y, et al. Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer. Nat Nanotechnol. 2019;14(5):496doi: 10.1038/s41565-019-0417-y.
Xu, J., Liu, Y., Li, Y., Wang, H., Stewart, S., Van der Jeught, K., Agarwal, P., Zhang, Y., Liu, S., Zhao, G., Wan, J., Lu, X., & He, X. (2019). Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer. Nature nanotechnology, 14(5), 496. https://doi.org/10.1038/s41565-019-0417-y
Xu, Jiangsheng, et al. "Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer." Nature nanotechnology vol. 14,5 (2019): 496. doi: https://doi.org/10.1038/s41565-019-0417-y
Xu J, Liu Y, Li Y, Wang H, Stewart S, Van der Jeught K, Agarwal P, Zhang Y, Liu S, Zhao G, Wan J, Lu X, He X. Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer. Nat Nanotechnol. 2019 May;14(5):496. doi: 10.1038/s41565-019-0417-y. PMID: 30837690.
Copy Download .nbib Format: NLM
Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer.

Nature nanotechnology

Xu J, Liu Y, Li Y, Wang H, Stewart S, Van der Jeught K, Agarwal P, Zhang Y, Liu S, Zhao G, Wan J, Lu X, He X.
PMID: 31953520
Nat Nanotechnol. 2020 Apr;15(4):342. doi: 10.1038/s41565-020-0635-3.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Cite
Xu J, Liu Y, Li Y, et al. Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer. Nat Nanotechnol. 2020;15(4):342doi: 10.1038/s41565-020-0635-3.
Xu, J., Liu, Y., Li, Y., Wang, H., Stewart, S., Van der Jeught, K., Agarwal, P., Zhang, Y., Liu, S., Zhao, G., Wan, J., Lu, X., & He, X. (2020). Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer. Nature nanotechnology, 15(4), 342. https://doi.org/10.1038/s41565-020-0635-3
Xu, Jiangsheng, et al. "Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer." Nature nanotechnology vol. 15,4 (2020): 342. doi: https://doi.org/10.1038/s41565-020-0635-3
Xu J, Liu Y, Li Y, Wang H, Stewart S, Van der Jeught K, Agarwal P, Zhang Y, Liu S, Zhao G, Wan J, Lu X, He X. Author Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer. Nat Nanotechnol. 2020 Apr;15(4):342. doi: 10.1038/s41565-020-0635-3. PMID: 31953520.
Copy Download .nbib Format: NLM
Activin A-derived human embryonic stem cells show increased competence to differentiate into primordial germ cell-like cells.

Stem cells (Dayton, Ohio)

Mishra S, Taelman J, Popovic M, Tilleman L, Duthoo E, van der Jeught M, Deforce D, van Nieuwerburgh F, Menten B, de Sutter P, Boel A, Chuva De Sousa Lopes SM, Heindryckx B.
PMID: 33470497
Stem Cells. 2021 May;39(5):551-563. doi: 10.1002/stem.3335. Epub 2021 Feb 02.

Protocols for specifying human primordial germ cell-like cells (hPGCLCs) from human embryonic stem cells (hESCs) remain hindered by differences between hESC lines, their derivation methods, and maintenance culture conditions. This poses significant challenges for establishing reproducible in vitro models...

Cite
Mishra S, Taelman J, Popovic M, et al. Activin A-derived human embryonic stem cells show increased competence to differentiate into primordial germ cell-like cells. Stem Cells. 2021;39(5):551-563doi: 10.1002/stem.3335.
Mishra, S., Taelman, J., Popovic, M., Tilleman, L., Duthoo, E., van der Jeught, M., Deforce, D., van Nieuwerburgh, F., Menten, B., de Sutter, P., Boel, A., Chuva De Sousa Lopes, S. M., & Heindryckx, B. (2021). Activin A-derived human embryonic stem cells show increased competence to differentiate into primordial germ cell-like cells. Stem cells (Dayton, Ohio), 39(5), 551-563. https://doi.org/10.1002/stem.3335
Mishra, Swati, et al. "Activin A-derived human embryonic stem cells show increased competence to differentiate into primordial germ cell-like cells." Stem cells (Dayton, Ohio) vol. 39,5 (2021): 551-563. doi: https://doi.org/10.1002/stem.3335
Mishra S, Taelman J, Popovic M, Tilleman L, Duthoo E, van der Jeught M, Deforce D, van Nieuwerburgh F, Menten B, de Sutter P, Boel A, Chuva De Sousa Lopes SM, Heindryckx B. Activin A-derived human embryonic stem cells show increased competence to differentiate into primordial germ cell-like cells. Stem Cells. 2021 May;39(5):551-563. doi: 10.1002/stem.3335. Epub 2021 Feb 02. PMID: 33470497; PMCID: PMC8248136.
Copy Download .nbib Format: NLM
Using iNaturalist to monitor adherence to best practices in bat handling.

Biodiversity data journal

Van der Jeucht L, Groom Q, Agosti D, Phelps K, Reeder DM, Simmons NB.
PMID: 34690513
Biodivers Data J. 2021 Sep 23;9:e68052. doi: 10.3897/BDJ.9.e68052. eCollection 2021.

No abstract available.

Cite
Van der Jeucht L, Groom Q, Agosti D, et al. Using iNaturalist to monitor adherence to best practices in bat handling. Biodivers Data J. 2021;9:e68052doi: 10.3897/BDJ.9.e68052.
Van der Jeucht, L., Groom, Q., Agosti, D., Phelps, K., Reeder, D. M., & Simmons, N. B. (2021). Using iNaturalist to monitor adherence to best practices in bat handling. Biodiversity data journal, 9e68052. https://doi.org/10.3897/BDJ.9.e68052
Van der Jeucht, Laura, et al. "Using iNaturalist to monitor adherence to best practices in bat handling." Biodiversity data journal vol. 9 (2021): e68052. doi: https://doi.org/10.3897/BDJ.9.e68052
Van der Jeucht L, Groom Q, Agosti D, Phelps K, Reeder DM, Simmons NB. Using iNaturalist to monitor adherence to best practices in bat handling. Biodivers Data J. 2021 Sep 23;9:e68052. doi: 10.3897/BDJ.9.e68052. eCollection 2021. PMID: 34690513; PMCID: PMC8484243.
Copy Download .nbib Format: NLM
Intratumoral delivery of mRNA: Overcoming obstacles for effective immunotherapy.

Oncoimmunology

Van der Jeught K, Van Lint S, Thielemans K, Breckpot K.
PMID: 26155403
Oncoimmunology. 2015 Feb 03;4(5):e1005504. doi: 10.1080/2162402X.2015.1005504. eCollection 2015 May.

The immunosuppressive tumor microenvironment (TME) is a major obstacle in cancer immunotherapy. Therefore, it has gained attention as a target site. mRNA emerged as a versatile drug class for cancer therapy. We reported that intratumoral administration of mRNA encoding...

Cite
Van der Jeught K, Van Lint S, Thielemans K, et al. Intratumoral delivery of mRNA: Overcoming obstacles for effective immunotherapy. Oncoimmunology. 2015;4(5):e1005504doi: 10.1080/2162402X.2015.1005504.
Van der Jeught, K., Van Lint, S., Thielemans, K., & Breckpot, K. (2015). Intratumoral delivery of mRNA: Overcoming obstacles for effective immunotherapy. Oncoimmunology, 4(5), e1005504. https://doi.org/10.1080/2162402X.2015.1005504
Van der Jeught, Kevin, et al. "Intratumoral delivery of mRNA: Overcoming obstacles for effective immunotherapy." Oncoimmunology vol. 4,5 (2015): e1005504. doi: https://doi.org/10.1080/2162402X.2015.1005504
Van der Jeught K, Van Lint S, Thielemans K, Breckpot K. Intratumoral delivery of mRNA: Overcoming obstacles for effective immunotherapy. Oncoimmunology. 2015 Feb 03;4(5):e1005504. doi: 10.1080/2162402X.2015.1005504. eCollection 2015 May. PMID: 26155403; PMCID: PMC4485825.
Copy Download .nbib Format: NLM
The metabolism of benzyladenine in Spathiphyllum floribundum 'Schott Petite' in relation to acclimatisation problems.

Plant cell reports

Werbrouck SP, van der Jeugt B, Dewitte W, Prinsen E, Van Onckelen HA, Debergh PC.
PMID: 24194317
Plant Cell Rep. 1995 Jul;14(10):662-5. doi: 10.1007/BF00232734.

In Spathiphyllum floribundum 'Petite', which was cultured on medium containing benzyladenine (BA), uptake of this cytokinin and its conversion to 9-ß-D-ribofuranosyl-benzyladenine (9R-BA) or 9-ß-glucopyranosyl-benzyladenine (9G-BA) was monitored. BA and extremely large quantities of 9G-BA were exclusively located in the...

Cite
Werbrouck SP, van der Jeugt B, Dewitte W, et al. The metabolism of benzyladenine in Spathiphyllum floribundum 'Schott Petite' in relation to acclimatisation problems. Plant Cell Rep. 1995;14(10):662-5doi: 10.1007/BF00232734.
Werbrouck, S. P., van der Jeugt, B., Dewitte, W., Prinsen, E., Van Onckelen, H. A., & Debergh, P. C. (1995). The metabolism of benzyladenine in Spathiphyllum floribundum 'Schott Petite' in relation to acclimatisation problems. Plant cell reports, 14(10), 662-5. https://doi.org/10.1007/BF00232734
Werbrouck, S P, et al. "The metabolism of benzyladenine in Spathiphyllum floribundum 'Schott Petite' in relation to acclimatisation problems." Plant cell reports vol. 14,10 (1995): 662-5. doi: https://doi.org/10.1007/BF00232734
Werbrouck SP, van der Jeugt B, Dewitte W, Prinsen E, Van Onckelen HA, Debergh PC. The metabolism of benzyladenine in Spathiphyllum floribundum 'Schott Petite' in relation to acclimatisation problems. Plant Cell Rep. 1995 Jul;14(10):662-5. doi: 10.1007/BF00232734. PMID: 24194317.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries